Onconova Therapeutics, Inc. Profile Avatar - Palmy Investing

Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that …

Biotechnology
US, Newtown [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Onconova Therapeutics, Inc. (ONTX) to it's peer group.

Peer Group
Loading...
End of ONTX's Analysis
CIK: 1130598 CUSIP: 68232V801 ISIN: US68232V8019 LEI: - UEI: -
Secondary Listings
ONTX has no secondary listings inside our databases.